Search

Search Constraints

You searched for: Author/Creator Awad, Mark M.

Search Results

1. Abstracts Presented by Attendees. (February 2016)

2. An open-label, phase II study of the polo-like kinase-1 (Plk-1) inhibitor, BI 2536, in patients with relapsed small cell lung cancer (SCLC). (February 2017)

3. Care disruptions among patients with lung cancer: A COVID-19 and cancer outcomes study. (October 2021)

4. Characterization of Non–Small-Cell Lung Cancers With MET Exon 14 Skipping Alterations Detected in Tissue or Liquid: Clinicogenomics and Real-World Treatment Patterns. (2021)

5. Characterization of Non–Small-Cell Lung Cancers With MET Exon 14 Skipping Alterations Detected in Tissue or Liquid: Clinicogenomics and Real-World Treatment Patterns. (25th August 2021)

10. Impact of MET inhibitors on survival among patients with non-small cell lung cancer harboring MET exon 14 mutations: a retrospective analysis. (July 2019)